Aiming to accelerate the competitiveness of UK business in the Biosciences
The BioVentures Interest Group provides mechanisms to enhance access to funding and the realisation of value, including:
- venture capital
- corporate investment
- joint ventures
The activities of the BioVentures Interest Group are guided by a Steering Committee of investors and companies with administrative resources provided by the Knowledge Transfer Network.
The key to success is the effective matching of needs and expectations. This is being achieved through targeted events that effectively utilise investor and business networks.
4th December 2012, Central London
Crowdfunding is fast becoming established in business minds as a means of funding businesses or projects with small contributions from large numbers of people. In 2011, Nesta estimated that $1.5 billion was raised through the initiative. It can provide a range of benefits for the ‘crowd' and early-access for businesses to people who can test and market an idea.
The BioVentures group held this event to help discover:
Whether early-stage bioscience companies with their roots in technology development can take advantage of crowdfunding.
Is equity crowfunding, where individuals receive small stakes in privately owned young businesses in return for risk-investment, a realistic alternative to traditional fund raising?
How does the model work and can it provide sufficient benefits for both businesses and investors?
Which businesses are actively facilitating equity crowdfunding and how is the investment regulated?
What happens later-on when the company needs more substantial follow-on investment perhaps from Angel or Venture Capital funds?
Is it an alternative source of growth capital for young bioscience companies?
21st March 2012, The Roslin Institute, Easter Bush Campus, EH25 9RG, Edinburgh
The "Pitch perfect" event was designed to assist small companies looking for funding with development of their pitches.
The event offered an opportunity for start-ups, spinouts and SMEs to hear from an experts view on the essential elements of a pitch; to deliver an eight minute pitch to a small panel and audience and receive constructive criticism on the proposition, its content and style. The evening provided an opportunity for observation of other pitches and a venue to meet and hear about other early-stage companies in the region.
- Elements of a Fundable Business Plan & What the KTN can do for you - Jayne Brookman, KTN
- Business Pitches followed by a feedback from a panel of experts
- Wine and networking
7th February 2012, The Roslin Institute near Edinburgh
Fundraising in the current climate is extremely difficult and requires more than good ideas or technologies, so the Bioventures group held a series of events to help develop early-stage ventures in the Biosciences sector (agri-food and IB).
15th June 2011, Pinsent Masons, London
This event was held to provide opportunities for investors to meet a range of innovative biotech companies at varying stages of growth with a desire to engage the investment community. The evening provided an opportunity to network with all stakeholders in the sector, including investors, entrepreneurs, technology providers, investment and legal service providers and technology companies.
8th February 2011, Butcher's Hall, London
Biotech is a diverse and core part of the high-value technology-driven economy of the future. With applications in fields spanning nutraceuticals, pest resistant crops, novel animal vaccines, biomaterials, chemicals, biofuels and industrial enzymes, non-medical biotech offers strong and robust investment opportunities underpinned by the UK's first class science base.
Biofuels have recently captured a lot of attention, and investment, but the scope of biological technologies is much wider. Biological systems can transform simple low cost substrates into a myriad of complex high value products. With ever-increasing economic drivers of efficiency and sustainability, biotechnology offers entrepreneurs and investors the opportunity to participate in the rapidly growing bioeconomy.
This event highlighted innovative approaches to investment in the sector and illustrate the range of commercial applications. It provided an opportunity to network with all stakeholders in the sector, including investors, entrepreneurs, technology providers, investment and legal service providers and technology companies.
Chaired by Pete Hotten CEO of Ploughshare Innovations Ltd (PIL)
PIL is the technology transfer company of the Defence Science & Technology Laboratory and offers a range of biotech and CleanTech opportunities in its portfolio.
New funding models to fit a new investment landscape - Martin Austin, founder of The BioIndustrial Finance Fund, Switzerland.
Removing investment bottlenecks in the emerging bioeconomy - Piers Clark, Isle Utilities Ltd, UK
Legal services to facilitate innovation - Louise Fullwood, Pinsent Masons, UK
Three presentations giving snapshots of investment opportunities in key subsectors: